The respiratory tract is one of the oldest routes used for the administration of drugs. Over the past decades inhalation therapy has established itself as a valuable tool in the local therapy of pulmonary diseases such as asthma or COPD (Chronic Obstructive Pulmonary Disease).This type of drug application in the therapy of these diseases is a clear form of targeted drug delivery to lungs.The drug used for asthma and COPD eg.- β2-agonists such as salbutamol (albuterol), Terbutalin formoterol, corticosteroids such as budesonide, Flixotide or beclomethasone and mast-cell stabilizers such as sodium cromoglycate or nedocromi are available like DPI (Dry Powder Inhaler),MDI (Metered Dose Inhaler) and Nebulizers.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Dr Karnakar Nampelly, M.Pharm, PhD., working as Head Department of Pharmaceutics, Venkateshwara Institute of Pharmaceutical Sciences, Nalgonda,Telangana. He has teaching experience of 10 years. He has published 2 patents in national journals, 19 research and review papers in various reputed national and international journals. Guided 30 projects.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Artikel-Nr. ria9786205631010_new
Anzahl: Mehr als 20 verfügbar
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Nasopulmonary Drug Delivery Systems | Inhalational Therapy | Nampelly Karnakar (u. a.) | Taschenbuch | Kartoniert / Broschiert | Englisch | 2023 | LAP LAMBERT Academic Publishing | EAN 9786205631010 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. Artikel-Nr. 126498855
Anzahl: 5 verfügbar